This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Chevron (CVX) upgraded to Sector Outperform from Sector Perform at Scotiabank; tgt raised to $200
> DraftKings (DKNG) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $17
> EOG Resources (EOG) upgraded to Sector Outperform from Sector Perform at Scotiabank; tgt lowered to $145
> Merck (MRK) upgraded to Buy from Neutral at Citigroup; tgt raised to $130
> Steven Madden (SHOO) upgraded to Buy from Neutral at Citigroup; tgt raised to $42
> SunPower (SPWR) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $15
> World Wrestling (WWE) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $120
> V.F. Corp (VFC) upgraded to Buy from Hold at Edward Jones
Downgrades:
> BRF SA (BRFS) downgraded to Underperform from Neutral at BofA Securities
> CubeSmart (CUBE) downgraded to Peer Perform from Outperform at Wolfe Research
> Exxon Mobil (XOM) downgraded to Sector Perform from Sector Outperform at Scotiabank; tgt lowered to $135
> First Solar (FSLR) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $230
> LSB Industries (LXU) downgraded to Hold from Buy at Jefferies; tgt lowered to $10
> LyondellBasell (LYB) downgraded to Hold from Buy at Jefferies; tgt lowered to $90
> National Storage Affiliates (NSA) downgraded to Underperform from Peer Perform at Wolfe Research
> Playtika (PLTK) downgraded to Underperform from Neutral at BofA Securities; tgt $10
> POSCO (PKX) downgraded to Underweight from Neutral at JP Morganowngrades:
Others:
> Broadcom (AVGO) initiated with a Buy at The Benchmark Company; tgt $770
> CCC Intelligent Solutions (CCCS) initiated with an Overweight at JP Morgan; tgt $11
> Costco (COST) initiated with an Outperform at William Blair
> CRISPR Therapeutics (CRSP) initiated with an Overweight at Cantor Fitzgerald; tgt $72
> FTC Solar (FTCI) initiated with a Buy at H.C. Wainwright; tgt $5
> General Motors (GM) initiated with a Neutral at Mizuho; tgt $39
> Intellia Therapeutics (NTLA) initiated with a Buy at Canaccord Genuity; tgt $66
> Magnite (MGNI) initiated with a Buy at B. Riley Securities; tgt $15
> Pliant Therapeutics (PLRX) initiated with an Outperform at Robert W. Baird; tgt $44
> Primerica (PRI) initiated with a Strong Buy at Raymond James; tgt $244
> PubMatic (PUBM) initiated with a Buy at B. Riley Securities; tgt $20
> Relay Therapeutics (RLAY) initiated with an Outperform at Raymond James; tgt $29
> RxSight (RXST) initiated with an Outperform at Oppenheimer; tgt $23
> Strategic Education (STRA) resumed with a Neutral at BofA Securities; tgt $103
> Verve Therapeutics (VERV) initiated with a Buy at Canaccord Genuity; tgt $29
> Vital Farms (VITL) initiated with a Hold at Needham
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
